SEROTONIN 5-HT2B INHIBITORY COMPOUNDS

    公开(公告)号:US20230071039A1

    公开(公告)日:2023-03-09

    申请号:US17870885

    申请日:2022-07-22

    IPC分类号: C07D451/04 C07D519/00

    摘要: The invention describes novel serotonin c5-HT2B receptor antagonists of Formula (1), and pharmaceutically acceptable salts thereof; wherein Ring A, L, X, X′, R3, R4, m and n are as defined herein. Also described are compositions comprising a Formula (1) compound, or a pharmaceutically acceptable salt thereof; and methods of using the compounds, or a pharmaceutically acceptable salt thereof, for the treatment of myxomatous mitral valve disease (MMVD), congestive heart failure (CHF) and/or asymptomatic heart failure in animals, preferably is a canine.